PL3464260T3 - Związki zawierające motyw mocznika i ich pochodne jako leki antybakteryjne - Google Patents

Związki zawierające motyw mocznika i ich pochodne jako leki antybakteryjne

Info

Publication number
PL3464260T3
PL3464260T3 PL17728481T PL17728481T PL3464260T3 PL 3464260 T3 PL3464260 T3 PL 3464260T3 PL 17728481 T PL17728481 T PL 17728481T PL 17728481 T PL17728481 T PL 17728481T PL 3464260 T3 PL3464260 T3 PL 3464260T3
Authority
PL
Poland
Prior art keywords
derivatives
containing compounds
antibacterial drugs
motif containing
urea
Prior art date
Application number
PL17728481T
Other languages
English (en)
Inventor
Philipp Le
Stephan Sieber
Elena KUNOLD
Original Assignee
Technische Universität München
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technische Universität München filed Critical Technische Universität München
Publication of PL3464260T3 publication Critical patent/PL3464260T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/30Derivatives containing the group >N—CO—N aryl or >N—CS—N—aryl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/38Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Emergency Medicine (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
PL17728481T 2016-05-30 2017-05-30 Związki zawierające motyw mocznika i ich pochodne jako leki antybakteryjne PL3464260T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16171906 2016-05-30
PCT/EP2017/063014 WO2017207556A2 (en) 2016-05-30 2017-05-30 Urea motif containing compounds and derivatives thereof as antibacterial drugs
EP17728481.7A EP3464260B8 (en) 2016-05-30 2017-05-30 Urea motif containing compounds and derivatives thereof as antibacterial drugs

Publications (1)

Publication Number Publication Date
PL3464260T3 true PL3464260T3 (pl) 2022-01-31

Family

ID=56087197

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17728481T PL3464260T3 (pl) 2016-05-30 2017-05-30 Związki zawierające motyw mocznika i ich pochodne jako leki antybakteryjne

Country Status (11)

Country Link
US (1) US12187696B2 (pl)
EP (1) EP3464260B8 (pl)
JP (1) JP7129085B2 (pl)
CN (1) CN109890804B (pl)
CA (1) CA3023040A1 (pl)
DK (1) DK3464260T3 (pl)
ES (1) ES2901164T3 (pl)
HU (1) HUE057798T2 (pl)
PL (1) PL3464260T3 (pl)
SG (1) SG11201809537VA (pl)
WO (1) WO2017207556A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017028745A1 (en) * 2015-08-17 2017-02-23 Chung-Wai Shiau Substituted malonamides and their use as antibacterial drugs
CN108785306B (zh) * 2018-09-09 2021-02-19 东北农业大学 索拉非尼在制备抑菌及干预致病菌生物被膜的药物中的用途
CN109456261A (zh) * 2018-12-05 2019-03-12 西安交通大学 一种基于vegfr-2抑制剂索拉菲尼的光亲合探针分子及其制备方法
CN113061126A (zh) * 2021-03-16 2021-07-02 无锡海伦生物科技有限公司 基于卤素中间体的索拉非尼光亲和探针分子的制备方法及应用
US11648248B1 (en) 2022-01-12 2023-05-16 King Abdulaziz University Potent antimicrobial compounds with a pyridazine nucleus
TW202339708A (zh) * 2022-04-13 2023-10-16 國立臺灣大學 抗微生物組合物、醫藥組合物及其用途
EP4554576A2 (en) * 2022-07-15 2025-05-21 University of Southern California Bifunctional photocrosslinking probes for covalent capture of protein-nucleic acid complexes in cells
CN117180254A (zh) * 2023-08-25 2023-12-08 华中科技大学协和深圳医院 Sc-43用于制备抗革兰氏阳性细菌感染药物中的应用
WO2025083280A1 (en) * 2023-10-19 2025-04-24 Universitat De Barcelona Sorafenib analogs for use in the treatment of cancer
EP4674846A1 (en) 2024-07-02 2026-01-07 Technische Universität München Urea motif containing compounds as antibacterial drugs against multiresistant mycobacteria

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL254871A (pl) * 1959-08-14
US3579578A (en) * 1966-07-08 1971-05-18 Givaudan Corp 3,4-dihalo-3' and 4'-lower alkylcarbanilides
US3503886A (en) * 1967-10-27 1970-03-31 Mary C Noel Antiseptic compositions
WO1989000563A1 (en) 1987-07-17 1989-01-26 The Nutrasweet Company High potency sweetening agents
JPH10109912A (ja) * 1996-10-04 1998-04-28 Akio Suganuma 抗菌組成物
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6093742A (en) * 1997-06-27 2000-07-25 Vertex Pharmaceuticals, Inc. Inhibitors of p38
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
AU757777B2 (en) * 1998-12-04 2003-03-06 Influx, Inc. Inhibitors of multidrug transporters
AU2002243439A1 (en) 2000-11-17 2002-07-24 Smithkline Beecham Corporation Fatty acid synthase inhibitors
KR20030080509A (ko) * 2002-04-09 2003-10-17 주식회사 엘지생명과학 우레아, 티오우레아 및 설파마이드 유도체를 함유하는항균제 조성물
EP1656341A1 (en) * 2003-07-09 2006-05-17 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
AU2005302669A1 (en) * 2004-10-27 2006-05-11 Neurogen Corporation Diaryl ureas as CB1 antagonists
WO2007101710A1 (en) 2006-03-09 2007-09-13 Cenix Bioscience Gmbh Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
FR2901792A1 (fr) * 2006-06-06 2007-12-07 Negma Lerads Soc Par Actions S DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE
EP2152260A1 (en) 2007-05-31 2010-02-17 Syntopix Group plc An antibacterial formulation comprising a dialkyl sulphosuccinate and a carbanilide antibacterial agent
WO2009035951A2 (en) 2007-09-11 2009-03-19 Arete Therapeutics, Inc. Soluble epoxide hydrolase inhibitors
KR20100096101A (ko) 2007-10-19 2010-09-01 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 박테리아 독성을 억제하는 방법 및 이에 대한 화합물
EP2385831A4 (en) 2009-01-09 2014-03-26 Uab Research Foundation SMALL MOLECULAR HEMMER OF NADS, NAMNAT AND NMNAT
CN103130686B (zh) 2011-12-02 2016-09-14 天津市国际生物医药联合研究院 N,n′-不对称二芳基取代脲类化合物及其制备方法和用途
WO2013142628A2 (en) 2012-03-20 2013-09-26 Fred Hutchinson Cancer Research Center Antibiotic compounds and compositions, and methods for identification thereof
US9951097B2 (en) 2012-12-04 2018-04-24 The Board Of Trustees Of The University Of Illinois Antibacterial compounds targeting isoprenoid biosynthesis
WO2015051149A1 (en) 2013-10-04 2015-04-09 The Trustees Of Columbia University In The City Of New York Sorafenib analogs and uses thereof
US9387186B2 (en) 2014-05-22 2016-07-12 Muhammad Iqbal Choudhary Thiourea derivatives

Also Published As

Publication number Publication date
EP3464260A2 (en) 2019-04-10
JP2019524644A (ja) 2019-09-05
US20210009550A1 (en) 2021-01-14
DK3464260T3 (da) 2021-12-20
CA3023040A1 (en) 2017-12-07
SG11201809537VA (en) 2018-12-28
CN109890804B (zh) 2026-02-24
ES2901164T3 (es) 2022-03-21
CN109890804A (zh) 2019-06-14
US12187696B2 (en) 2025-01-07
EP3464260B8 (en) 2022-02-16
HUE057798T2 (hu) 2022-06-28
EP3464260B1 (en) 2021-10-27
WO2017207556A2 (en) 2017-12-07
WO2017207556A3 (en) 2018-01-11
WO2017207556A4 (en) 2018-03-22
JP7129085B2 (ja) 2022-09-01

Similar Documents

Publication Publication Date Title
PL3464260T3 (pl) Związki zawierające motyw mocznika i ich pochodne jako leki antybakteryjne
IL258082B (en) History of benzaimidazole and pharmaceutical preparations containing them
EP3169671A4 (en) Substituted urea derivatives and pharmaceutical uses thereof
IL254552A0 (en) Polycyclic carbamoylpyridone compounds and their pharmaceutical uses
SG11201706877RA (en) Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same
IL247062A0 (en) Heterocyclic compounds, their preparation and pharmaceutical preparations containing them
EP3280578A4 (en) Antimicrobial articles and compounds therefor
ZA201805523B (en) Antibacterial compounds and uses thereof
IL253538B (en) Heterocyclic compound and pharmaceutical compound containing it
HUP1400075A2 (hu) Sirolimus és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói
IL248744A0 (en) History of heterocyclic butanamides, their preparation and drugs containing them
ZA201802033B (en) Heteroaryl compounds and their use as therapeutic drugs
IL271824A (en) Compounds containing a flavone derivative and uses thereof
PT3202759T (pt) Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo
IL272385A (en) Drug compound and methods of preparation
ZA201900421B (en) Novel quinazolinone derivatives inhibiting pi3k and pharmaceutical composition containing same
PL4056557T3 (pl) Pochodne benzoazepiny użyteczne jako leki
ZA202000959B (en) Adamantylmethylamine derivative and use thereof as pharmaceutical
ZA201901945B (en) Tetrahydropyridine derivatives and their use as antibacterial agents
IL246629A0 (en) Pharmaceutical preparations containing a derivative of benzonitrile and gefitinib
ZA201904313B (en) Heterocyclic derivatives as antibacterial compounds
GB201516610D0 (en) Antibacterial compounds and new uses thereof